Arrestin‐independent internalization of the GLP ‐1 receptor is facilitated by a GRK , clathrin, and caveolae‐dependent mechanism
The FEBS Journal · 2025
DOI: 10.1111/febs.17338 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Ee Von Moo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Design and Pharmacology, University of Copenhagen, Denmark. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor, Caveolae, Clathrin, Arrestin. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: HORIZON EUROPE Marie Sklodowska-Curie Actions, Japan Agency for Medical Research and Development, Novo Nordisk Fonden.
Abstract (Originalsprache)
The glucagon‐like peptide‐1 receptor (GLP‐1R) plays an important role in regulating insulin secretion and reducing body weight, making it a prominent target in the treatment of type 2 diabetes and obesity. Extensive research on GLP‐1R signaling has provided insights into the connection between receptor function and physiological outcomes, such as the correlation between Gs signaling and insulin secretion, yet the exact mechanisms regulating signaling remain unclear. Here, we explore the internalization pathway of GLP‐1R, which is crucial for controlling insulin release and maintaining pancreatic beta‐cell function. Utilizing a reliable and sensitive time‐resolved fluorescence resonance energy transfer (TR‐FRET) internalization assay, combined with HEK293‐derived knockout cell lines, we were able to directly compare the involvement of different endocytic machinery in GLP‐1R internalization. Our findings indicate that the receptor internalizes independently of arrestin and is dependent on Gs and Gi/o activation and G protein–coupled receptor kinase phosphorylation. Mechanistically, we observed that the receptor undergoes distinct clathrin‐ and caveolae‐mediated internalization in HEK293 cells. This study also investigated the role of arrestins in GLP‐1R function and regulation. These insights into key endocytic components that are involved in the GLP‐1R internalization pathway could enhance the rational design of GLP‐1R therapeutics for type 2 diabetes and other GLP‐1R‐related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Design and Pharmacology, University of Copenhagen, Denmark.
- Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
- Graduate School of Pharmaceutical Sciences, Kyoto University, Japan.
ORCID-Profile: Ee Von Moo
Förderung
- HORIZON EUROPE Marie Sklodowska-Curie Actions
- Japan Agency for Medical Research and Development
- Novo Nordisk Fonden
- Japan Science and Technology Agency
- Japan Society for the Promotion of Science
- Danmarks Frie Forskningsfond
Zitieren
APA
Moo, E. V., Møller, T. C., Sørensen, F. A., Inoue, A., & Bräuner-Osborne, H. (2025). Arrestin‐independent internalization of the GLP ‐1 receptor is facilitated by a GRK , clathrin, and caveolae‐dependent mechanism. The FEBS Journal. https://doi.org/10.1111/febs.17338
Vancouver
Moo EV, Møller TC, Sørensen FA, Inoue A, Bräuner-Osborne H. Arrestin‐independent internalization of the GLP ‐1 receptor is facilitated by a GRK , clathrin, and caveolae‐dependent mechanism. The FEBS Journal. 2025. doi:10.1111/febs.17338
BibTeX
@article{Moo2025,
author = {Moo, Ee Von and Møller, Thor Christian and Sørensen, Frederikke Astrid and Inoue, Asuka and Bräuner-Osborne, Hans},
title = {Arrestin‐independent internalization of the GLP ‐1 receptor is facilitated by a GRK , clathrin, and caveolae‐dependent mechanism},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.17338}
}
EUVIMED